Esperion Therapeutics acquired by Essence Parent for $3.16 per share plus contingent payments
Essence Parent Inc. completed its acquisition of Esperion Therapeutics on July 13, 2026, with shareholders receiving $3.16 per share in cash plus one…
$3.16per share$100M